JP Patent

JP7802200B2 — 置換のアミノ６員窒素複素環式化合物の塩及びその結晶形、製造方法と応用

Assigned to Shanghai Institute of Materia Medica of CAS · Expires 2026-01-19 · 0y expired

What this patent protects

Patent listed against infigratinib-phosphate.

Drugs covered by this patent

infigratinib-phosphate (INFIGRATINIB PHOSPHATE)

Patent Metadata

Patent number: JP7802200B2
Jurisdiction: JP
Classification: —
Expires: 2026-01-19
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Institute of Materia Medica of CAS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.